Strikingly, c‐Myc and XBP1s transcriptional activities are positively correlated in multiple prostate cancer patient cohorts, underscoring the fact that these two critical transcription factors are often concurrently activated in prostate cancer (Sheng et al, 2019). Here, MYC is linked to prostate carcinoma.